Skip to main content

Syndicate contentDrug Discovery

Diabetes surgery summit consensus lays foundation for new field of medicine

NEW YORK (Nov. 23, 2009) -- A first-of-its-kind consensus statement on diabetes surgery is published online today in the Annals of Surgery.

University of Minnesota invention will help speed development of drug treatments for heart failure

Research conducted by University of Minnesota scientists, in collaboration with Celladon Corporation, has led to the invention of technology to more rapidly identify compounds for the treatment of heart failure.

Power to the People!

November 13, 2009 by DuncanAzzopardi

This week I attended a meeting held by the Society for Genomics Policy and Public Health entitled ‘Genetics and Health Promotion’. It was extremely interesting and posed two very significant questions. How do scientists translate genetic research into effective therapeutics and how is this then effectively pitched to public health strategists?

Aileron collaborates study in Nature: Stapled peptides inhibit Notch1 transcription factor

CAMBRIDGE, MA -- November 11, 2009 -- Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides, announced today that its collabora

New imagining technique could lead to better antibiotics and cancer drugs

COLLEGE STATION -- A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, sa

Tiny injector to speed development of new, safer, cheaper drugs

It's no bigger than a stamp packet but it has the potential to allow rapid development of a new generation of drugs and genetic engineering organisms, and to better control in-vitro fertilization.<

Scientists develop novel method to generate functional hepatocytes for drug testing

Scientists have for the first time produced liver cells from adult skin cells using the induced pluripotent stem cell (iPSC) technology.

The study, led by the University of Edinburgh's MRC Centre for Regenerative Medicine, paves the way for the creation of a stem cell library that can be used for in vitro hepatic disease models.

Fate Therapeutics announces creation of small molecule platform for commercial-scale reprogramming

La Jolla, CA -- October 18, 2009 -- Fate Therapeutics, Inc. announced today the generation of human induced-pluripotent stem cells (iPSCs) using a combination of small molecules that significantly improves the speed and efficiency of reprogramming. The discoveries, which were made by Sheng Ding, Ph.D.

Pitt researchers find candidates for new HIV drugs

PITTSBURGH, Oct. 13 -- While studying an HIV protein that plays an essential role in AIDS progression, researchers at the University of Pittsburgh School of Medicine have discovered compounds that show promise as novel treatments for the disease.

Drug discovery process more accurate, less expensive using novel mass spectrometry application

CINCINNATI -- Cancer and cell biology experts at the University of Cincinnati (UC) have developed a new mass spectrometry-based tool they say provides more precise, cost-effective data collection for drug discovery efforts.

SRI to present hydrogen fuel safety research results at 2009 International Conference

SRI International, an independent nonprofit research and development organization, announced today it will present new research identifying methods for designing safer structures in the future for hydrogen fueled vehicles, at the upcoming International Conference on Hydrogen Safety, Sept. 16 - 18, in Ajaccio?Corsica, France.

Enzyme inhibitor takes an unexpected approach toward blocking cancer-promoting protein

Scientists at Fox Chase Cancer Center have discovered a unique method of attack that may be used to inhibit signaling enzymes called kinases, which often have a role in sustaining drug-resistant cancerous cells.

Dynamic changes in DNA linked to human diabetes

A study in the September issue of Cell Metabolism, a Cell Press publication, may give new meaning to the adage, "You are what you eat."

Millionths of a second can cost millions of dollars: A new way to track network delays

Computer scientists have developed an inexpensive solution for diagnosing networking delays in data center networks as short as tens of millionths of seconds -- delays that can lead to multi-million dollar losses for investment banks running automatic stock trading systems.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.


Premium Drupal Themes by Adaptivethemes